(Total Views: 577)
Posted On: 10/02/2020 6:18:08 PM
Post# of 145889
SAF,
M/m larger population. Question is willingness to pay.east economic argument for severe/critical, cancer, HIV.
Less so for mild/moderate especially in populations not considered at high risk.
I am not betting on Covid for huge revenues, just as the all important first step/first approval.
M/m larger population. Question is willingness to pay.east economic argument for severe/critical, cancer, HIV.
Less so for mild/moderate especially in populations not considered at high risk.
I am not betting on Covid for huge revenues, just as the all important first step/first approval.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)